The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: AT 3, AT III, Functional Antithrombin III
The Antithrombin III Activity test contains 1 test with 1 biomarker.
Brief Description: The Antithrombin III Activity test measures the activity of antithrombin, a protein in the blood that naturally inhibits clot formation. It's one of the primary inhibitors of clotting factor enzymes, particularly thrombin and Factor Xa. Adequate antithrombin levels are vital for controlling and balancing coagulation. The activity test provides insights into how well the antithrombin is functioning, rather than just its concentration in the blood.
Collection Method: Blood Draw
Specimen Type: Plasma
Test Preparation: No preparation required
An Antithrombin III Activity test may be ordered:
The Antithrombin III Activity test checks for the functionality of antithrombin in the blood. It assesses how effectively antithrombin can inhibit clotting enzymes, indicating whether an individual has a normal ability to prevent excessive clotting.
When an Antithrombin III Activity test is ordered, it's often part of a broader assessment of clotting disorders. Here are some tests commonly ordered alongside it:
Protein C and Protein S Activity:
Activated Partial Thromboplastin Time (aPTT):
Prothrombin Time (PT) and International Normalized Ratio (INR):
Factor V Leiden and Prothrombin G20210A Mutation Tests:
Lupus Anticoagulant and Anticardiolipin Antibodies:
These tests, when ordered alongside an Antithrombin III Activity test, provide a comprehensive evaluation of a person's risk for thrombophilia. They are crucial for identifying the cause of clotting disorders, assessing the risk of future clotting events, and guiding treatment and management decisions. The specific combination of tests will depend on the individual’s clinical history, family history, and any previous episodes of abnormal clotting.
Several conditions or situations might prompt the use of this test:
The results of the Antithrombin III Activity test can provide crucial information about an individual's risk of developing blood clots:
Healthcare providers may also use the test results to monitor the effectiveness of treatment, particularly if antithrombin concentrates are being administered or if the patient is on anticoagulant therapy.
Why is the Antithrombin III Activity test performed?
The Antithrombin III Activity test is performed to measure the activity of antithrombin, a protein that helps regulate blood clotting. By inhibiting certain clotting factors, antithrombin prevents excessive clotting, which can lead to thrombotic events such as deep vein thrombosis or pulmonary embolism.
How does Antithrombin III function in the body?
Antithrombin III functions as a primary inhibitor of thrombin and certain other clotting factors. When it binds to these clotting factors, it inactivates them, preventing the conversion of fibrinogen to fibrin, which is a key step in blood clot formation. Therefore, Antithrombin III plays a critical role in maintaining a balance between bleeding and clotting.
What do decreased levels of Antithrombin III activity indicate in the Antithrombin III Activity test results?
Decreased levels of Antithrombin III activity can suggest a higher risk of excessive clotting. This could be due to a hereditary deficiency, where a person is born with low levels of antithrombin, or an acquired deficiency, which could result from conditions like liver disease, disseminated intravascular coagulation (DIC), or vitamin K deficiency.
What might elevated levels of Antithrombin III activity mean in the Antithrombin III Activity test results?
Elevated levels of Antithrombin III activity are less common and can be seen in certain conditions, such as after antithrombin supplementation or treatment. They may also be seen during certain stages of pregnancy, but it's less often associated with an increased clinical risk compared to decreased levels.
How is the Antithrombin III Activity test used in the management of patients on anticoagulant therapy?
For patients on anticoagulant therapy, especially heparin, the Antithrombin III Activity test is crucial. Heparin enhances the activity of antithrombin, making it more effective in inhibiting clotting factors. If a patient has a deficiency of antithrombin and is administered heparin, the drug may not be as effective. Thus, monitoring antithrombin levels in such patients ensures the effectiveness of heparin therapy.
How often should the Antithrombin III Activity test be done for those with known deficiencies?
For individuals with known antithrombin deficiencies, the frequency of the Antithrombin III Activity test varies based on clinical circumstances. Those who have had thrombotic events or are at a high risk might need more frequent monitoring, especially if they are on anticoagulant therapy. However, specific testing frequency should be individualized based on clinical judgment and the patient's history.
Are there specific conditions or diseases that affect Antithrombin III levels in the Antithrombin III Activity test?
Yes, various conditions can affect Antithrombin III levels. Liver disease can lead to decreased production of antithrombin, resulting in lowered levels. Nephrotic syndrome, a kidney condition, can lead to increased loss of antithrombin in urine. Disseminated intravascular coagulation (DIC), a complex systemic thrombohemorrhagic disorder, can consume antithrombin, also leading to decreased levels. Other conditions, such as inflammatory disorders, certain infections, or post-surgical states, may also affect antithrombin levels.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.